Efficacy and tolerability of various bowel preparations in diabetic patients: a randomized controlled trial

Abstract

Background and study aims Diabetes mellitus (DM) is an independent risk factor for poor bowel preparation prior to colonoscopy. Bisacodyl is a stimulant laxative that may mitigate colonic dysmotility associated with diabetes. We hypothesized that adding bisacodyl to split-dose bowel preparation (SDBP) would improve the quality of bowel preparation among patients with diabetes.

Patients and methods Adult outpatients aged 18 to 80 years undergoing colonoscopy were recruited. One hundred and eighty-six patients with diabetes were randomly assigned to 1 of 3 treatment arms: 1) conventional 4 L of polyethylene glycol electrolyte lavage solution (PEG-ELS; conventional bowel preparation [CBP]); 2) split-dose of 4 L PEG-ELS (split-dose bowel preparation [SDBP]); or 3) split-dose of 4 L PEG-ELS preceded by 10 mg of oral bisacodyl 10 (SDBP-B). The primary outcome measure was bowel cleansing as indicated by Boston Bowel Preparation Scale (BBPS) score. Endoscopists were blinded to the preparation used. Secondary outcome measures were safety and patient tolerability.

Results Of the 212 patients randomized, only 186 received assigned bowel preparation. There were no differences among the three study groups with regard to age, indication, duration of DM, insulin use, narcotic use, or presence of end-organ diabetic complications. There was a trend toward better bowel preparation quality among those receiving SDBP and SDBP-B compared to those receiving CBP, but the trend was not statistically significant  ≥ 6 BBPS; 67 % vs. 83 % vs. 75 %, P = 0.1). In terms of safety and tolerability, there were no differences among the three groups.

Conclusion Adding bisacodyl to SDBP does not improve the quality of bowel preparation in patients with DM. Further efforts are needed to optimize colonoscopy bowel preparation in this population.

• References

• 1 Winawer SJ, Zauber AG, Ho MN. The National Polyp Study Workgroup. et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981
• 2 Kim WH, Cho YJ, Park JY. et al. Factors affecting insertion time and patient discomfort during colonoscopy. Gastrointest Endosc 2000; 52: 600-605
• 3 Ness RM, Manam R, Hoen H. et al. Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol 2001; 96: 1797-1802
• 4 Rex DK, Imperiale TF, Latinovich DR. et al. Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol 2002; 97: 1696-1700
• 5 Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc 2003; 58: 76-79
• 6 Fayad NF, Kahi CJ, Abd El-Jawad KH. et al. Association between body mass index and quality of split bowel preparation. Clin Gstroenterolo Hepatol 2013; 11: 1478-1485
• 7 Dik VK, Moons LM, Huyuk M. et al. Predicting inadequate bowel preparation for colonoscopy in participants receiving split-dose bowel preparation: development and validation of a prediction score. Gastrointest Endosc 2015; 81: 665-672
• 8 Bytzer P, Talley NJ, Leemon M. et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161: 1989-1996
• 9 Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98: 378-384
• 10 Parkman HP, Yates K, Hasler WL. et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 1056-1064 ; quiz e133-134
• 11 La VecchiaC, Negri E, Decarli A. et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6: 1007-1010
• 12 Will JC, Galuska DA, Vinicor F. et al. Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol 1998; 147: 816-825
• 13 Taylor C, Schubert ML. Decreased efficacy of polyethylene glycol lavage solution (golytely) in the preparation of diabetic patients for outpatient colonoscopy: a prospective and blinded study. Am J Gastroenterol 2001; 96: 710-714
• 14 Ozturk NA, Gokturk HS, Demir M. et al. Efficacy and safety of sodium phosphate for colon cleansing in type 2 diabetes mellitus. South Med J 2010; 103: 1097-1102
• 15 Alvarez-Gonzalez MA, Flores-Le Roux JA, Seoane A. et al. Efficacy of a multifactorial strategy for bowel preparation in diabetic patients undergoing colonoscopy: a randomized trial. Endoscopy 2016; 48: 1003-1009
• 16 Madhoun MF, Bitar H, Bhatti O. et al. Diabetics on narcotics are less likely to achieve excellent bowel preparation than are patients with either condition. Dig Dis Sci 2017; 62: 723-729
• 17 Grigg E, Schubert MC, Hall J. et al. Lubiprostone used with polyethylene glycol in diabetic patients enhances colonoscopy preparation quality. World J Gstrointest Endosc 2010; 2: 263-267
• 18 Hayes A, Buffum M, Hughes J. Diabetic colon preparation comparison study. Gastroenterol Nurs 2011; 34: 377-82
• 19 Johnson DA, Barkun AN, Cohen LB. et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2014; 109: 1528-1545
• 20 Battle WM, Snape Jr WJ, Alavi A. et al. Colonic dysfunction in diabetes mellitus. Gastroenterology 1980; 79: 1217-1221
• 21 Sims MA, Hasler WL, Chey WD. et al. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans. Gastroenterology 1995; 108: 350-359
• 22 Herve S, Savoye G, Behbahani A. et al. Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterol Motil 2004; 16: 397-402
• 23 Kilgore TW, Abdinoor AA, Szary NM. et al. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc 2011; 73: 1240-1245